• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIOSENSE WEBSTER INC QDOT MICRO, BI, TC, D-F; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIOSENSE WEBSTER INC QDOT MICRO, BI, TC, D-F; CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION Back to Search Results
Catalog Number D139505
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Unspecified Infection (1930); Laceration(s) of Esophagus (2398)
Event Date 12/19/2022
Event Type  Death  
Event Description
During a clinical trial, sponsored by biosense webster inc., was reported that a patient underwent an atrial fibrillation (afib) ablation procedure with a qdot-micro, bi-directional, d-f curve, c3, split handle catheter under general anesthesia.The patient experienced bloody, necrotic esophageal stenosis requiring surgical intervention.The patient ultimately passed away.On (b)(6) 2022, patient experienced bloody, necrotic esophageal stenosis categorized as severe and serious as defined by prolonged hospitalization from (b)(6) 2022 the patient ultimately passed away.Relationship to study device is not related and relationship to primary study procedure is causal relationship to the index procedure.The adverse event is unexpected/unanticipated.The outcome is fatal.Intervention was surgery, stenting.
 
Manufacturer Narrative
E1.Initial reporter phone: (b)(6).Since no device has been received for analysis, no product investigation can be performed, and the customer complaint cannot be confirmed.A manufacturing record evaluation was performed for the finished device 30874958l number, and no internal action related to the complaint was found during the review.This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by biosense webster, inc., or its employees that the report constitutes an admission that the product, biosense webster, inc., or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.This report is being submitted late due to a retrospective review of complaints for the qdot micro products.Biosense webster¿s investigation determined that upon approval of qdot in the united states on november 23, 2022, the electronic complaints system was not updated and therefore medical device reports were not submitted in a timely manner.Through biosense webster¿s investigation it was determined that this was an isolated case.An internal action was opened to address this issue.Manufacturer's ref.No: (b)(4).
 
Manufacturer Narrative
On 25-mar-2024, an update was made to the clinical database.It was noted that there was no stenting done.The surgical intervention was removed from the treatment section.Therefore, the h 6.Health effect - impact code of ¿surgical intervention (f19)¿ was removed.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's reference number: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
QDOT MICRO, BI, TC, D-F
Type of Device
CATHETER, PERCUTANEOUS, CARDIAC ABLATION, FOR TREATMENT OF ATRIAL FIBRILLATION
Manufacturer (Section D)
BIOSENSE WEBSTER INC
31 technology drive, suite 200
irvine CA 92618
Manufacturer (Section G)
BIOSENSE WEBSTER INC (JUAREZ)
circuito interior norte
1820parque industrial salvacar
juarez 32599
MX   32599
Manufacturer Contact
kate karberg
31 technology dr
irvine, CA 92618
3035526892
MDR Report Key17620292
MDR Text Key321916816
Report Number2029046-2023-01883
Device Sequence Number1
Product Code OAE
UDI-Device Identifier10846835016758
UDI-Public10846835016758
Combination Product (y/n)N
Reporter Country CodeBE
PMA/PMN Number
P210027
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional,Company Representative
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 04/18/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received08/24/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberD139505
Device Lot Number30874958L
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received03/25/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2022
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NGEN RF GENERATOR; OCTA,LNG,48P,2-5-2-5-2,D-CURVE; UNK_CARTO 3
Patient Outcome(s) Hospitalization; Required Intervention; Death;
Patient Age80 YR
Patient SexFemale
Patient Weight26 KG
-
-